The Failure of Chemotherapy – As More Patients Abstain From The Treatment More Survive
DECEMBER 6, 2016 by DAVE MIHALOVIC
Prevent Disease Cancer cases have increased by more than 30 percent in the last decade and half of all cases globally are ending up in deaths according to a new report from the Global Burden of Disease Cancer Collaboration published online by JAMA Oncology. Moreover, the overall contribution of cytotoxic chemotherapy to 5-year survival in adults is below 3 percent.
Cancers figure among the leading causes of morbidity and mortality worldwide. Between 2005 and 2015, cancer cases increased by 33 percent and the number of new cases is expected to rise by about 70% over the next just two decades under the current global disease promoting paradigm.
Cancer is part of the conglomerate of preventable disease which makes up approximately 80% percent of the burden of illness and 90% of all healthcare costs.
The report by Christina Fitzmaurice, M.D., M.P.H., of the University of Washington, Seattle and coauthors estimated cancer deaths using vital registration system data, cancer registry incidence data and verbal autopsy data.
Other key findings from the report were:
Globally, the odds of developing cancer during a lifetime were 1 in 3 for men and 1 in 4 for women.
Prostate cancer was the most common cancer globally in men (1.6 million cases); tracheal, bronchus and lung (TBL) cancer was the leading cause of cancer deaths for men.
Breast cancer was the most common cancer for women (2.4 million cases) and the leading cause of cancer deaths in women.
The most common childhood cancers were leukemia, other neoplasms, non-Hodgkin lymphoma, and brain and nervous system cancers.
“Semblance is all about illusion,” says oncologist Dr. Maven Rowland. “We given a false appearance of what cancer is and how we can treat it and unfortunately we do not have a detailed understanding from a medical perspective of cancer burden or how to treat its growing incidence in the global epidemiological and demographic transition.”
Part of the failure in treating cancer is our reliance on cytotoxic drugs, especially conventional chemotherapy used broadly across the world. As more people abstain from using chemotherapy as a treatment for cancer, more people are surviving.
Oncologists recommend cytotoxic chemotherapy for most patients in for the palliation of symptoms and to and to improve quality of life. It is aims at improving survival. None of the above has materialized as truth for the cancer industry since the inception of the treatment and despite the use of new and expensive single and combination drugs to improve response rates and other agents to allow for dose escalation, there has been no change for the regimens used.
The largest majority of patients who undergo chemotherapy and make it to the five year mark and never actually cancer free. Most statistics simply highlight that patients are “still alive” at the five year mark. Most still had cancer and many died of cancer later.
Those who do survive have a significantly depreciated quality of life. This has come at an enormous cost to our elders, for they are suffering with more pain and greater disability than ever before in last 15 years of life.
If a “magic bullet” were used FIRST by orthodox medicine, meaning the cut/burn/slash/poison treatments were avoided, a 90% true cure rate would be easy to achieve. But the fact is that the leaders in the medical community have absolutely no interest in finding a “magic bullet.” A “magic bullet” would cost the drug companies hundreds of billions of dollars, and patients would have less hospitalization and less doctor visits, etc.
Chemotherapy does not target cancer cells, and because of this, chemotherapy: 1) Kills far more normal cells than cancer cells, and 2) Damages and toxifies many of the normal cells that do survive.
So why does chemotherapy kill so many people? Why does concentrated cyanide kill you? How do anthrax, arsenic, and zyklon B kill you? They are all poisons. Consume or inject enough poison into your body and you will eventually die. Toxic chemotherapy drugs just happen to take a little longer than many of those above, and they’re designed that way.
According to official statistics, one person out of two is claimed to recover from cancer through conventional methods. Although dramatic, the information nevertheless contains a certain amount of hope, as implicitly it provides something positive for both scientists and patients. To the scientists it says: continue the research because it is producing results; do not try preventive, alternative theoretical or therapeutic roads, nor get discouraged by the fact that patients keep on dying every day. To the patients, on the other hand, it provides a warning: you have a 50 percent chance of making it, as long as you follow the conventional therapeutic protocols without trying what they claim are the useless alternatives.
There is an international classification (the TNM system) that classifies tumors on the basis of their gravity. They are subdivided into stages I, II, III, IV, and into sub-groups. It is clear to any trained eye that initial lesions that are doubtful or at the limit of malignancy represent the overwhelming majority of the observed “neoplasias”.
It is equally clear how often these presumed neoplasias, which are often subject to both misunderstanding and manipulation, inflate those statistics to the point of implausibility.
So, in the early stages of tumors (the dubious ones) the recovery rates are extremely high, while in the following stages — that is, where they certainly are tumors — the rates are barely above zero. The reason for the discrepancy is the qualification of the data and how a patient is assessed in terms of recovery. Immune reconstitution and tolerance, organ and metabolic toxicities, endocrine challenges, functional outcomes, quality of life, and neurocognitive outcomes are NEVER inclusively assessed in any clinical study discussing the long-term survival and recovery rates of cancer patients. The damage to these systems slowly develops after chemotherapy, however if often does not begin to manifest throughout the body until several months or even years have passed. It takes time, but within a 3-5 year period, most chemotherapy patients begin to have many more symptoms of disease than they every had before their diagnosis, due to and as a direct result of cytotoxic drug intervention.
Adjuvant chemotherapy is often given to patients who might not really need it at all. Oncologists do not consider the whole spectrum of chemotherapy risks versus benefits and thus compromise quality of life for every patient they treat. A study in the Annals of Oncology is one of few which assessed the different potential long-term adverse events associated with adjuvant chemotherapy in cancer, with a particular focus on long-term cardiac toxicity, secondary leukemia, cognitive function, and neurotoxicity. The authors stated that the adverse events are frequently overshadowed by the well-demonstrated clinical efficacy and/or reassuring short-term safety profiles of the different chemotherapy regimens commonly used today.
Another study in the American Society of Clinical Oncology determined whether long-term survivors of metastatic testicular cancer have an increased risk of cardiovascular morbidity more than 10 years after chemotherapy. They observed a significantly increased risk for occurrence of cardiac events accompanied by a persisting unfavorable cardiovascular risk profile likely due to chemotherapeutic agents.
Peter Glidden, BS, ND in the video above describes the 12-year meta-analysis published in the Journal of Clinical Oncology which observed adults who had developed cancer and treated with chemotherapy. The 12-year study looked at adults who had developed cancer as an adult. 97% of the time, chemotherapy did not work in regressing the metastatic cancers.How Chemotherapy Actually Boosts Cancer Growth
Researchers tested the effects of a type of chemotherapy on tissue collected from men with prostate cancer, and found “evidence of DNA damage” in healthy cells after treatment, the scientists wrote in Nature Medicine.
Chemotherapy works by inhibiting reproduction of fast-dividing cells such as those found in tumours.
The scientists found that healthy cells damaged by chemotherapy secreted more of a protein called WNT16B which boosts cancer cell survival.
“The increase in WNT16B was completely unexpected,” study co-author Peter Nelson of the Fred Hutchinson Cancer Research Center in Seattle told AFP.
The protein was taken up by tumour cells neighbouring the damaged cells.
“WNT16B, when secreted, would interact with nearby tumour cells and cause them to grow, invade, and importantly, resist subsequent therapy,” said Nelson.
In cancer treatment, tumours often respond well initially, followed by rapid regrowth and then resistance to further chemotherapy.
Rates of tumour cell reproduction have been shown to accelerate between treatments.
“Our results indicate that damage responses in benign cells… may directly contribute to enhanced tumour growth kinetics,” wrote the team.
The researchers said they confirmed their findings with breast and ovarian cancer tumours.
Patients with incurable cancers are promised much greater access to the latest drugs which could offer them extra months or years of life, however many doctors have been urged to be more cautious in offering cancer treatment to terminally-ill patients as chemotherapy can often do more harm than good, advice supported by Nelson’s study.
Doctors Speak Out About The Cancer Industry
Dr. Robert Atkins, MD, of Atkins Diet fame once announced there are several cures for cancer, but there’s no money in them. They’re natural, effective, and inexpensive, no expensive drugs are involved but they require quite a lot of self-discipline from patients. It costs millions to fund research and clinical trials needed to produce a new cancer drug that can be patented and sold. Often these drugs create more illness. It has been said that the key to success in the health business is to pull off the trick of making people patients for life. Consider how many people who registered a couple of abnormal blood pressure readings have been kept on medication until the medication killed them, when a quick fix course of drugs supported by major changes of diet and lifestyle would have returned their physical condition to an unmedicated healthy state.
According to Dr. John Diamond, M.D., “A study of over 10,000 patients shows clearly that chemo’s supposedly strong track record with Hodgkin’s disease (lymphoma) is actually a lie. Patients who underwent chemo were 14 times more likely to develop leukemia and 6 times more likely to develop cancers of the bones, joints, and soft tissues than those patients who did not undergo chemotherapy.”
Dr. Glenn Warner, who died in 2000, was one of the most highly qualified cancer specialists in the United States. He used alternative treatments on his cancer patients with great success. On the treatment of cancer in this country he said: “We have a multi-billion dollar industry that is killing people, right and left, just for financial gain. Their idea of research is to see whether two doses of this poison is better than three doses of that poison.”
Dr. Alan C. Nixon, past president of the American Chemical Society writes, “As a chemist trained to interpret data, it is incomprehensible to me that physicians can ignore the clear evidence that chemotherapy does much, much more harm than good.” And according to Dr. Charles Mathe, French cancer specialist, “…if I contracted cancer, I would never go to a standard cancer treatment centre. Only cancer victims who live far from such centres have a chance.”
Dr. Allen Levin stated: “Most cancer patients in this country die of chemotherapy. Chemotherapy does not eliminate breast, colon, or lung cancers. This fact has been documented for over a decade, yet doctors still use chemotherapy for these tumors.” In his book, The Topic of Cancer: When the Killing Has to Stop, Dick Richards cites a number of autopsy studies which have shown that cancer patients actually died from conventional treatments before the tumor had a chance to kill them.